Origins and treatment of airway inflammation in childhood asthma

Pediatric Pulmonology

Volumn , Issue SUPPL. 21, 2001, Pages 17-25

  Lemanske Jr , Robert F ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Asthma; Leukotriene receptor antagonists; Respiratory syncytial virus

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CYTOKINE; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ASTHMA; ATOPY; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; FIBROSIS; HUMAN; LOWER RESPIRATORY TRACT INFECTION; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFLAMMATION; RISK FACTOR; VIRUS INFECTION; CELLULAR IMMUNITY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; PHYSIOLOGY; RESPIRATORY TRACT INFECTION; REVIEW;

ADRENAL CORTEX HORMONES; ASTHMA; CHILD; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNITY, CELLULAR; INFLAMMATION; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 0034954330     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.2002     Document Type: Conference Paper

References (42)

1. Association of radiologically ascertained pneumonia before age 3 years with asthmalike symptoms and pulmonary function during childhood: A prospective study
2. Asthma and wheezing in the first six years of life
3. Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk
4. Hay fever, eczema, and wheeze: A nationwide UK study (ISAAC, international study of asthma and allergies in childhood)
5. Is enhanced fetal growth a risk factor for the development of atopy or asthma?
6. The intrauterine and postnatal environments
7. The prevalence of allergic disease and linoleic acid in the diet
8. Can we predict which wheezy infants will continue to wheeze?
9. Environmental tobacco smoke, wheezing, and asthma in children in 24 communities
10. Bacterial flora of the lower respiratory tract in children with bronchial asthma
11. Protection against atopic diseases by measles - A rash conclusion?
12. The role of allergy in the development of asthma
13. Relationship between fetal growth and the development of asthma and atopy in childhood
14. The use of antibiotics in the first year of life and development of asthma: Which comes first?
15. Day care attendance, recurrent respiratory tract infections and asthma
16. Pre- and perinatal risk factors for asthma in inner city African-American children
17. Beyond breast-feeding
18. Risk factors for early, persistent, and late-onset wheezing in young children
19. Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions
20. The association between early life lung function and wheezing during the first 2 years of life
21. Virus-induced airway hyperresponsiveness and asthma
22. Early life origins of asthma
23. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
24. Chronic, episodic, reversible airway obstruction after viral bronchiolitis in rats
25. Prevention of chronic postbronchiolitis airway sequelae with IFN-gamma treatment in rats
26. Transplacental priming of the human immune system to environmental allergens: Universal skewing of initial T cell responses toward the TH2 cytokine profile
27. Maternal programming in asthma and allergy
28. Reduced interferon-gamma secretion in neonates and subsequent atopy
29. Reduced interferon-gamma production in infants with bronchiolitis and asthma
30. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing
31. Asthma. From bronchoconstriction to airways inflammation and remodeling
32. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis
33. Bronchoalveolar lavage findings suggest two different forms of childhood asthma
34. Effect of continuous treatment with topical cortiocosteroid on episodic viral wheeze in preschool children
35. Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers
36. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes
37. Clinical evidence with montelukast in the management of chronic childhood asthma
38. Montelukast for chronic asthma in 6- to 14-year-old children: A randomized, double-blind trial
39. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: Role in obstructive airway disease
40. 4 in bronchiolitis due to respiratory syncytial virus
41. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis
42. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast